tm logo
DAZLUMA
Live/Registered
REGISTERED

on 13 Feb 2024

Last Applicant/ Owned by

Ritter House, P.O. Box 173

Road Town, Tortola

VG

VG1110

Serial Number

90232661 filed on 02th Oct 2020

Registration Number

7305018 registered on 13th Feb 2024

in the Principal Register

Correspondent Address

Monica Riva Talley STERNE KESSLER GOLDSTEIN & FOX PLLC

1101 K. Street, N.W.

10th Floor

WASHINGTON, DC 20005

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

DAZLUMA

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, for the treatment of neuroinflammatory and neurodegenerative diseases and disorders, and for neuroprotection

Classification Information


Class [005]
Pharmaceutical Products


Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, for the treatment of neuroinflammatory and neurodegenerative diseases and disorders, and for neuroprotection


First Use Date in General

15th Nov 2023

First Use Date in Commerce

16th Nov 2023

Mark Details


Serial Number

No 90232661

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 4501.0570000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
22nd Feb 2024TEAS SECTION 7 REQUEST RECEIVED
13th Feb 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
13th Feb 2024REGISTERED-PRINCIPAL REGISTER
09th Jan 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06th Jan 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15th Dec 2023STATEMENT OF USE PROCESSING COMPLETE
13th Dec 2023USE AMENDMENT FILED
13th Dec 2023TEAS STATEMENT OF USE RECEIVED
28th Oct 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27th Oct 2023SOU EXTENSION 5 GRANTED